Integrating Clinical, Genetic, and Electrocardiogram-Based Artificial Intelligence to Estimate Risk of Incident Atrial Fibrillation

Shinwan Kany,Joel Ramo,Sam Freesun Friedman,Lu-Chen Weng,Carolina Roselli,Min Seo Kim,Akl Fahed,Steven Lubitz,Mahnaz Maddah,Patrick Ellinor,Shaan Khurshid
DOI: https://doi.org/10.1101/2024.08.13.24311944
2024-08-14
Abstract:Background: AF risk estimation is feasible using clinical factors, inherited predisposition, and artificial intelligence (AI)-enabled electrocardiogram (ECG) analysis. Objective: To test whether integrating these distinct risk signals improves AF risk estimation. Methods: In the UK Biobank prospective cohort study, we estimated AF risk using three models derived from external populations: the well-validated Cohorts for Aging in Heart and Aging Research in Genomic Epidemiology AF (CHARGE-AF) clinical score, a 1,113,667-variant AF polygenic risk score (PRS), and a published AI-enabled ECG-based AF risk model (ECG-AI). We estimated discrimination of 5-year incident AF using time-dependent area under the receiver operating characteristic (AUROC) and average precision (AP). Results: Among 49,293 individuals (mean age 65+-8 years, 52% women), 825 (2.4%) developed AF within 5 years. Using single models, discrimination of 5-year incident AF was higher using ECG-AI (AUROC 0.705 [95%CI 0.686-0.724]; AP 0.085 [0.071-0.11]) and CHARGE-AF (AUROC 0.785 [0.769-0.801]; AP 0.053 [0.048-0.061]) versus the PRS (AUROC 0.618, [0.598-0.639]; AP 0.038 [0.028-0.045]). The inclusion of all components ('Predict-AF3') was the best performing model (AUROC 0.817 [0.802-0.832]; AP 0.11 [0.091-0.15], p<0.01 vs CHARGE-AF+ECG-AI), followed by the two component model of CHARGE-AF+ECG-AI (AUROC 0.802 [0.786-0.818]; AP 0.098 [0.081-0.13]). Using Predict-AF3, individuals at high AF risk (i.e., 5-year predicted AF risk >2.5%) had a 5-year cumulative incidence of AF of 5.83% (5.33-6.32). At the same threshold, the 5-year cumulative incidence of AF was progressively higher according to the number of models predicting high risk (zero: 0.67% [0.51-0.84], one: 1.48% [1.28-1.69], two: 4.48% [3.99-4.98]; three: 11.06% [9.48-12.61]), and Predict-AF3 achieved favorable net reclassification improvement compared to both CHARGE-AF+ECG-AI (0.039 [0.015-0.066]) and CHARGE-AF+PRS (0.033 [0.0082-0.059]). Conclusions: Integration of clinical, genetic, and AI-derived risk signals improves discrimination of 5-year AF risk over individual components. Models such as Predict-AF3 have substantial potential to improve prioritization of individuals for AF screening and preventive interventions.
What problem does this paper attempt to address?
This paper aims to solve how to more accurately estimate the risk of atrial fibrillation (AF) by integrating clinical factors, genetic information and artificial intelligence (AI) - analyzed electrocardiograms (ECGs). Specifically, the researchers hope to test the following hypothesis: whether combining these different risk signals can improve the prediction accuracy of AF risk. ### Background Atrial fibrillation is a common arrhythmia, which is associated with an increased risk of stroke, heart failure and death. Early diagnosis of atrial fibrillation and preventive treatment (such as anticoagulant treatment) can reduce related complications. However, the existing screening methods have limited effectiveness in diagnosing atrial fibrillation and have not significantly improved hard - end - point indicators such as stroke or mortality. ### Research Objectives The main objective of the study is to evaluate whether integrating three different types of atrial fibrillation risk signals, namely clinical factors, genetic information and AI - analyzed electrocardiograms, can improve the prediction accuracy of the risk of atrial fibrillation occurring within 5 years. ### Methods The study used data from the UK Biobank, which is a prospective cohort study of nearly 50,000 participants. The researchers adopted the following three models: 1. **CHARGE - AF**: An atrial fibrillation prediction score based on clinical risk factors. 2. **Polygenic Risk Score (PRS)**: An atrial fibrillation risk score based on common genetic variants. 3. **ECG - AI**: An atrial fibrillation risk model based on artificial intelligence - analyzed electrocardiograms. The researchers evaluated the prediction performance of each model when used alone, and further constructed combined models, including two - component models (CHARGE - AF + PRS, CHARGE - AF + ECG - AI, ECG - AI + PRS) and a three - component model (Predict - AF3, that is, CHARGE - AF + PRS + ECG - AI). ### Results - **Single models**: - ECG - AI has the highest prediction performance (AUROC 0.705, AP 0.085). - CHARGE - AF is second (AUROC 0.785, AP 0.053). - PRS is the lowest (AUROC 0.618, AP 0.038). - **Combined models**: - **Predict - AF3** is the best - performing model (AUROC 0.817, AP 0.11), significantly superior to other combined models. - Among the two - component models, CHARGE - AF + ECG - AI performs best (AUROC 0.802, AP 0.098). ### Conclusions The research results show that integrating three different types of risk signals, namely clinical, genetic and AI - analyzed electrocardiograms, can significantly improve the prediction accuracy of the risk of atrial fibrillation within 5 years. In particular, the Predict - AF3 model has the highest prediction performance and has important clinical application potential, and can better prioritize high - risk individuals for atrial fibrillation screening and preventive interventions. ### Keywords Atrial fibrillation, Genetics, Precision medicine, Risk prediction, Stroke, Screening